Polaroid says medical unit reduces loss

Article

Polaroid reported that its Polaroid Medical Imaging Systems divisionhas been making progress in reducing its red ink. The Cambridge,MA, firm made the announcement as part of second-quarter resultsreleased this month. Revenues for the PMIS unit, which

Polaroid reported that its Polaroid Medical Imaging Systems divisionhas been making progress in reducing its red ink. The Cambridge,MA, firm made the announcement as part of second-quarter resultsreleased this month.

Revenues for the PMIS unit, which manufactures and sells theHelios dry-process laser printer, have been increasing at thesame time that development costs are dropping, Polaroid said.The results are in line with the division's effort to shift froman R&D mode to a more entrepreneurial structure in line withPolaroid's broader restructuring effort (SCAN 4/24/96 and 12/27/95).

Polaroid said that sales of Helios film more than doubled inthe second quarter of 1996 compared with the same period lastyear. Hardware shipments for the period were at the same levelas last year's second quarter, Polaroid said.

Polaroid did not break out revenue numbers for PMIS, but forthe company as a whole, Polaroid reported second-quarter revenuesof $581.6 million, up 2% compared with $572.5 million in the sameperiod in 1995. The company had a net loss of $26 million comparedwith a net profit of $22.9 million a year ago.

The company's net loss was attributed to a $54.5 million one-timecharge associated with its purchase of conversion rights for subordinateddebentures. Without the charge, Polaroid had earnings of $28.5million, up 24%.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.